<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE book-part-wrapper PUBLIC "-//NLM//DTD BITS Book Interchange DTD v2.0 20151225//EN" "http://jats.nlm.nih.gov/extensions/bits/2.0/BITS-book2.dtd">
<book-part-wrapper id="cherubism" content-type="chapter" from-where="body" dtd-version="2.0">
  <book-meta>
    <book-id book-id-type="pmcid">gene</book-id>
    <book-title-group>
      <book-title>GeneReviews<sup>&#x000ae;</sup></book-title>
    </book-title-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Adam</surname>
          <given-names>Margaret P</given-names>
        </name>
        <role>Editor-in-Chief</role>
      </contrib>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ardinger</surname>
          <given-names>Holly H</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Pagon</surname>
          <given-names>Roberta A</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Wallace</surname>
          <given-names>Stephanie E</given-names>
        </name>
      </contrib>
      <role>Senior Editors</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Bean</surname>
          <given-names>Lora JH</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Mefford</surname>
          <given-names>Heather C</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Stephens</surname>
          <given-names>Karen</given-names>
        </name>
      </contrib>
      <role>Molecular Genetics</role>
    </contrib-group>
    <contrib-group>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Amemiya</surname>
          <given-names>Anne</given-names>
        </name>
      </contrib>
      <contrib contrib-type="editor">
        <name name-style="western">
          <surname>Ledbetter</surname>
          <given-names>Nikki</given-names>
        </name>
      </contrib>
      <role>Genetic Counseling</role>
    </contrib-group>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>1993</year>
    </pub-date>
    <pub-date publication-format="electronic" date-type="pubr">
      <year>2017</year>
    </pub-date>
    <issn>2372-0697</issn>
    <publisher>
      <publisher-name>University of Washington, Seattle</publisher-name>
      <publisher-loc>Seattle (WA)</publisher-loc>
    </publisher>
    <permissions>
      <copyright-statement>Copyright &#x000a9; 1993-2017, University of Washington, Seattle. GeneReviews is a registered trademark of the University of Washington, Seattle. All rights reserved.</copyright-statement>
      <copyright-year>2017</copyright-year>
      <license xmlns:xlink="http://www.w3.org/1999/xlink" license-type="open-access" xlink:href="https://www.ncbi.nlm.nih.gov/books/NBK138602/">
        <license-p>GeneReviews&#x000ae; chapters are owned by the University of Washington. Permission is hereby granted to reproduce, distribute, and translate copies of content materials for noncommercial research purposes only, provided that (i) credit for source (<ext-link ext-link-type="uri" xlink:href="http://www.genereviews.org/">http://www.genereviews.org/</ext-link>) and copyright (&#x000a9; 1993-2017 University of Washington) are included with each copy; (ii) a link to the original material is provided whenever the material is published elsewhere on the Web; and (iii) reproducers, distributors, and/or translators comply with the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>. No further modifications are allowed. For clarity, excerpts of GeneReviews chapters for use in lab reports and clinic notes are a permitted use.</license-p>
        <license-p>For more information, see the <related-object source-id="gene" document-id="GRcopyright_permiss">GeneReviews&#x000ae; Copyright Notice and Usage Disclaimer</related-object>.</license-p>
        <license-p>For questions regarding permissions or whether a specified use is allowed, contact: <email>admasst@uw.edu</email>.</license-p>
      </license>
    </permissions>
    <custom-meta-group>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Genetics</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Medicine</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-subject</meta-name>
        <meta-value>Diseases</meta-value>
      </custom-meta>
      <custom-meta>
        <meta-name>books-source-type</meta-name>
        <meta-value>Database</meta-value>
      </custom-meta>
    </custom-meta-group>
    <notes notes-type="ednotes">
      <p content-type="genetic_counseling">
<italic toggle="yes">Genetic counseling is the process of
providing individuals and families with information on the nature, inheritance,
and implications of genetic disorders to help them make informed medical and
personal decisions. The following section deals with genetic risk assessment and
the use of family history and genetic testing to clarify genetic status for
family members. This section is not meant to address all personal, cultural, or
ethical issues that individuals may face or to substitute for consultation with
a genetics professional</italic>. &#x02014;ED.</p>
      <p content-type="resources">
<italic toggle="yes">GeneReviews staff has selected the following disease-specific and/or
umbrella support organizations and/or registries for the benefit of individuals
with this disorder and their families. GeneReviews is not responsible for the
information provided by other organizations. For information on selection
criteria, click <related-object source-id="gene" document-id="app4">here</related-object>.</italic></p>
    </notes>
  </book-meta>
  <book-part book-part-type="chapter">
    <book-part-meta>
      <book-part-id book-part-id-type="pmcid">cherubism</book-part-id>
      <title-group>
        <title>Cherubism</title>
      </title-group>
      <contrib-group>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Baskin</surname>
            <given-names>Berivan</given-names>
          </name>
          <degrees>PhD, FCCMG, FACMG</degrees>
          <email>berivan.baskin@akademiska.se</email>
          <aff>Clinical Genetics<break/>Uppsala University Hospital<break/>Uppsala, Sweden </aff>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Bowdin </surname>
            <given-names>Sarah</given-names>
          </name>
          <degrees>BM, MSc, MRCPCH (UK)</degrees>
          <email>sarah.bowdin@sickkids.ca</email>
          <aff>Staff Physician, Division of Clinical and Metabolic Genetics<break/>The Hospital for Sick Children<break/>Assistant Professor, University of Toronto<break/>Toronto, Ontario</aff>
        </contrib>
        <contrib contrib-type="author">
          <name name-style="western">
            <surname>Ray</surname>
            <given-names>Peter N</given-names>
          </name>
          <degrees>PhD, FCCMG, FACMG</degrees>
          <email>peter.ray@sickkids.ca</email>
          <aff>Head, Division of Molecular Genetics<break/>The Hospital for Sick Children<break/>Professor, Department of Molecular and Medical Genetics<break/>University of Toronto<break/>Toronto, Ontario </aff>
        </contrib>
      </contrib-group>
      <pub-history>
        <date iso-8601-date="2007-02-26" date-type="created">
          <day>26</day>
          <month>2</month>
          <year>2007</year>
        </date>
        <date iso-8601-date="2011-09-01" date-type="updated">
          <day>1</day>
          <month>9</month>
          <year>2011</year>
        </date>
      </pub-history>
      <related-object link-type="parent-book-link" source-id="gene">GeneReviews<sup>&#x000ae;</sup></related-object>
      <related-object link-type="previous-part-link" source-id="gene" document-id="chediak-higashi" document-type="chapter">Chediak-Higashi Syndrome</related-object>
      <related-object link-type="next-part-link" source-id="gene" document-id="cach" document-type="chapter">Childhood Ataxia with Central Nervous System Hypomyelination/Vanishing White Matter</related-object>
      <abstract id="cherubism.Summary">
        <title>Summary</title>
        <sec>
          <title>Clinical characteristics</title>
          <p>Cherubism is characterized by progressive, painless, bilateral enlargement of the mandible and/or maxilla resulting from replacement of bone with multilocular cysts composed of fibrotic stromal cells and osteoclast-like cells. The enlargement is usually symmetric in nature. The phenotype ranges from no clinical manifestations to severe mandibular and maxillary overgrowth with respiratory, vision, speech, and swallowing problems. Onset is typically between ages two and five years. Other bones are usually not affected and the affected person is otherwise normal. The jaw lesions progress slowly until puberty when they stabilize and then regress. Dental abnormalities include congenitally missing teeth, premature exfoliation of the deciduous teeth, and displacement of permanent teeth by the jaw lesions. By age 30 years, facial abnormalities are no longer apparent; residual jaw deformity is rare. </p>
        </sec>
        <sec>
          <title>Diagnosis/testing</title>
          <p>Diagnosis depends on typical clinical findings and radiographic findings of well-defined, often extensive bilateral multilocular areas of diminished density in the mandible and/or maxilla. <italic toggle="yes">SH3BP2</italic> is the only gene in which mutation is currently known to cause cherubism. Sequence analysis of exon 9 is typically performed first as most missense mutations identified to date are in exon 9. </p>
        </sec>
        <sec>
          <title>Management</title>
          <p><italic toggle="yes">Treatment of manifestations</italic>: Care by a craniofacial team in a major pediatric medical center; surgery (curettage with or without bone grafting) as needed between ages five to 15 years for disfiguring enlargement of jaws or locally aggressive lesions; orthodontic treatment; ophthalmologic treatment for displacement of the globe or vision loss. </p>
          <p><italic toggle="yes">Prevention of secondary complications</italic>: Early orthodontia and/or jaw reconstruction may reduce risk for upper airway obstruction, obstructive sleep apnea, and tooth displacement. </p>
          <p><italic toggle="yes">Surveillance:</italic> Long-term follow up with clinical, radiographic, dental, orthodontic, and ophthalmologic evaluations. </p>
          <p><italic toggle="yes">Testing of relatives at risk</italic>: When the disease-causing mutation in the family is known, molecular testing can be used to identify mildly affected relatives who may benefit from early intervention; otherwise, clinical and radiographic evaluations can identify relatives at risk. </p>
        </sec>
        <sec>
          <title>Genetic counseling</title>
          <p>Cherubism is inherited in an autosomal dominant manner. The proportion of cases caused by <italic toggle="yes">de novo</italic> mutations is unknown because of variable expressivity and reduced penetrance. Each child of an individual with cherubism has a 50% chance of inheriting the mutation. Prenatal diagnosis for pregnancies at increased risk is possible if the disease-causing mutation has been identified in the family.</p>
        </sec>
      </abstract>
    </book-part-meta>
    <body>
      <sec id="cherubism.Diagnosis">
        <title>Diagnosis</title>
        <sec id="cherubism.Clinical_Diagnosis">
          <title>Clinical Diagnosis</title>
          <p>Diagnosis of cherubism is made on the presence of clinical findings and radiographic and histologic manifestations and is confirmed with molecular genetic testing of <italic toggle="yes">SH3BP2</italic>. </p>
          <p>No clinical diagnostic criteria have been established. However, the diagnosis is suspected in individuals with the following findings:</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Clinical findings</bold>
</p>
              <list list-type="bullet">
                <list-item>
                  <p>Onset usually between age two and five years </p>
                </list-item>
                <list-item>
                  <p>Painless bilateral, symmetric enlargement of the mandible and/or maxilla including coronoids and condyles. Other cranial bones are usually unaffected. </p>
                </list-item>
                <list-item>
                  <p>Slow progression of the jaw lesions up to adolescence and spontaneous regression typically starting after puberty and extending into the twenties </p>
                </list-item>
                <list-item>
                  <p>Upturned tilting of eyeballs (in advanced stages); rim of sclera visible beneath iris </p>
                </list-item>
                <list-item>
                  <p>Dental abnormalities: congenitally missing second and third molars; premature exfoliation of the deciduous teeth and displacement of permanent teeth secondary to the jaw lesions </p>
                </list-item>
              </list>
            </list-item>
            <list-item>
              <p><bold>Radiographic manifestations</bold> in the mandible and/or maxilla: well-defined bilateral multilocular areas of diminished density, very often extensive, with few irregular bony septa </p>
            </list-item>
            <list-item>
              <p><bold>Histologic manifestations</bold> of lesions in the mandible and/or maxilla: non-neoplastic fibrotic lesions that contain numerous multinuclear giant cells and occasionally cysts. Increase in osteoid and newly formed bone matrix is observed in the periphery. </p>
            </list-item>
          </list>
          <p>Concentrations of alkaline phosphatase, parathyroid hormone, and calcium are normal, thus eliminating the diagnosis of hyperparathyroidism.</p>
        </sec>
        <sec id="cherubism.Molecular_Genetic_Testing">
          <title>Molecular Genetic Testing</title>
          <p><bold>Gene.</bold>
<italic toggle="yes">SH3BP2</italic> is the only gene in which mutation is known to cause cherubism. </p>
          <p><bold>Evidence for locus heterogeneity.</bold> Failure to identify a <italic toggle="yes">SH3BP2</italic> pathogenic variant in 20% of affected individuals suggests possible genetic heterogeneity [<xref ref-type="bibr" rid="cherubism.REF.ueki.2001.125">Ueki et al 2001</xref>]. </p>
          <p><bold>Clinical testing</bold>
</p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Sequence analysis</bold> of exon 9 of <italic toggle="yes">SH3BP2</italic> detects an estimated 80% of mutations in individuals tested [<xref ref-type="bibr" rid="cherubism.REF.ueki.2001.125">Ueki et al 2001</xref>]. The mutations are missense and are clustered within a six-amino acid sequence. Mutations in remaining exons are rare. </p>
            </list-item>
          </list>
          <table-wrap id="cherubism.T.summary_of_molecular_genetic" position="anchor" orientation="portrait">
            <label>Table 1. </label>
            <caption>
              <p>Summary of Molecular Genetic Testing Used in Cherubism</p>
            </caption>
            <table frame="hsides" rules="groups">
              <thead>
                <tr>
                  <th id="hd_h_cherubism.T.summary_of_molecular_genetic_1_1_1_1" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Gene&#x000a0;<sup>1</sup></th>
                  <th id="hd_h_cherubism.T.summary_of_molecular_genetic_1_1_1_2" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Test Method</th>
                  <th id="hd_h_cherubism.T.summary_of_molecular_genetic_1_1_1_3" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Mutations Detected</th>
                  <th id="hd_h_cherubism.T.summary_of_molecular_genetic_1_1_1_4" valign="middle" align="left" scope="col" rowspan="1" colspan="1">Mutation Detection Frequency by Test Method&#x000a0;<sup>2</sup></th>
                </tr>
              </thead>
              <tbody>
                <tr>
                  <td headers="hd_h_cherubism.T.summary_of_molecular_genetic_1_1_1_1" rowspan="2" valign="middle" align="left" scope="row" colspan="1">
                    <italic toggle="yes">SH3BP2</italic>
                  </td>
                  <td headers="hd_h_cherubism.T.summary_of_molecular_genetic_1_1_1_2" valign="middle" align="left" rowspan="1" colspan="1">Sequence analysis&#x000a0;<sup>3</sup> of select exons</td>
                  <td headers="hd_h_cherubism.T.summary_of_molecular_genetic_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants in exon 9 </td>
                  <td headers="hd_h_cherubism.T.summary_of_molecular_genetic_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">~80%&#x000a0;<sup>4</sup></td>
                </tr>
                <tr>
                  <td headers="hd_h_cherubism.T.summary_of_molecular_genetic_1_1_1_2" valign="middle" colspan="1" align="left" scope="row" rowspan="1">Sequence analysis&#x000a0;<sup>3</sup></td>
                  <td headers="hd_h_cherubism.T.summary_of_molecular_genetic_1_1_1_3" valign="middle" align="left" rowspan="1" colspan="1">Sequence variants</td>
                  <td headers="hd_h_cherubism.T.summary_of_molecular_genetic_1_1_1_4" valign="middle" align="left" rowspan="1" colspan="1">&#x0003e;80%</td>
                </tr>
              </tbody>
            </table>
            <table-wrap-foot>
              <fn id="cherubism.TF.1.1">
                <label>1. </label>
                <p>See <related-object source-id="gene" document-id="cherubism" object-id="cherubism.molgen.TA">Table A. Genes and Databases</related-object> for chromosome locus and protein. See <xref ref-type="sec" rid="cherubism.Molecular_Genetics">Molecular Genetics</xref> for information on allelic variants. </p>
              </fn>
              <fn id="cherubism.TF.1.2">
                <label>2. </label>
                <p>The ability of the test method used to detect a mutation that is present in the indicated gene</p>
              </fn>
              <fn id="cherubism.TF.1.3">
                <label>3. </label>
                <p>Sequence analysis detects variants that are benign, likely benign, of unknown significance, likely pathogenic, or pathogenic. Pathogenic variants may include small intragenic deletions/insertions and missense, nonsense, and splice site variants; typically, exonic or whole-gene deletions/duplications are not detected. For issues to consider in interpretation of sequence analysis results, click <related-object link-type="booklink" source-id="gene" document-id="app2" document-type="appendix">here</related-object>.</p>
              </fn>
              <fn id="cherubism.TF.1.4">
                <label>4. </label>
                <p>
                  <xref ref-type="bibr" rid="cherubism.REF.ueki.2001.125">Ueki et al [2001]</xref>
                </p>
              </fn>
            </table-wrap-foot>
          </table-wrap>
        </sec>
        <sec id="cherubism.Testing_Strategy">
          <title>Testing Strategy</title>
          <p><bold>To confirm/establish the diagnosis in a proband.</bold> Molecular genetic testing is used to confirm the diagnosis in a proband with the suggestive clinical findings and typical radiologic and/or histologic manifestations (see <xref ref-type="sec" rid="cherubism.Clinical_Diagnosis">Clinical Diagnosis</xref>). </p>
          <list list-type="bullet">
            <list-item>
              <p>Sequence analysis of exon 9 is typically performed first. </p>
            </list-item>
            <list-item>
              <p>Sequencing of the remaining exons of <italic toggle="yes">SH3BP2</italic> is performed on individuals in whom a mutation in exon 9 is not identified.</p>
            </list-item>
          </list>
          <p><bold>Prenatal diagnosis and preimplantation genetic diagnosis (PGD)</bold> for at-risk pregnancies require prior identification of the disease-causing mutations in the family.</p>
        </sec>
      </sec>
      <sec id="cherubism.Clinical_Description">
        <title>Clinical Characteristics</title>
        <sec id="cherubism.Natural_History">
          <title>Clinical Description</title>
          <p>Individuals with cherubism are normal at birth. Usually, cherubism manifests in early childhood (age 2-5 years) and progresses until puberty when it begins to stabilize and starts to regress. By age 30 years, the facial abnormalities are not usually recognizable and residual deformity of the jaws is rare [<xref ref-type="bibr" rid="cherubism.REF.von_wowern.2000.765">Von Wowern 2000</xref>].</p>
          <p>Aside from the facial anomalies described, cherubism is an isolated benign condition; the affected person is mentally and otherwise physically normal.</p>
          <p>The symptoms and signs of cherubism are related to the severity of the condition, and range from clinically unrecognized features to severely deformed mandibular and maxillary overgrowth with respiratory, speech, and swallowing complications [<xref ref-type="bibr" rid="cherubism.REF.roginsky.2009.218">Roginsky et al 2009</xref>]. Massive enlargement of the jaws is common and can also be associated with severe pain [<xref ref-type="bibr" rid="cherubism.REF.battaglia.2000.573">Battaglia et al 2000</xref>, <xref ref-type="bibr" rid="cherubism.REF.timo_ca.2000.336">Timo&#x0015f;ca et al 2000</xref>, <xref ref-type="bibr" rid="cherubism.REF.silva.2002.45">Silva et al 2002</xref>, <xref ref-type="bibr" rid="cherubism.REF.gomes.2005.313">Gomes et al 2005</xref>, <xref ref-type="bibr" rid="cherubism.REF.wang.2006.322">Wang et al 2006</xref>].</p>
          <p>In some studies, males were found to be more commonly and severely affected than females [<xref ref-type="bibr" rid="cherubism.REF.von_wowern.2000.765">Von Wowern 2000</xref>]. </p>
          <p><bold>Involvement of cranial bones.</bold> The disease starts with rapid bone degradation, usually restricted to the mandibular and maxillary regions, and leads to multiple symmetric cystic changes. These cysts are filled with fibrous tissue mass that consists of stromal cells and osteoclast-like cells, resulting in the typical facial phenotype [<xref ref-type="bibr" rid="cherubism.REF.ozkan.2003.1005">Ozkan et al 2003</xref>]. </p>
          <p><bold>Dental.</bold> In most affected persons, teeth are displaced, unerupted, unformed, or absent, or may appear to be floating in cystlike spaces. Malocclusion, premature exfoliation of deciduous teeth, and root resorption have also been reported [<xref ref-type="bibr" rid="cherubism.REF.kozakiewicz.2001.123">Kozakiewicz et al 2001</xref>]. </p>
          <p><bold>Orbital and ophthalmologic.</bold> In rare instances, enlargement of the maxilla and penetration of the stromal mass into the orbital floor can cause lower lid retraction, proptosis, diploia, globe displacement, and/or visual loss as a result of optic atrophy [<xref ref-type="bibr" rid="cherubism.REF.carroll.2001.38">Carroll &#x00026; Sullivan 2001</xref>, <xref ref-type="bibr" rid="cherubism.REF.font.2003.1846">Font et al 2003</xref>]. </p>
          <p><bold>Respiratory.</bold> Respiratory problems can include obstructive sleep apnea and upper airway obstruction caused by backward displacement of the tongue [<xref ref-type="bibr" rid="cherubism.REF.battaglia.2000.573">Battaglia et al 2000</xref>, <xref ref-type="bibr" rid="cherubism.REF.ladhani.2003.552">Ladhani et al 2003</xref>]. </p>
        </sec>
        <sec id="cherubism.GenotypePhenotype_Correlations">
          <title>Genotype-Phenotype Correlations</title>
          <p>No genotype/phenotype correlations have been described for cherubism. </p>
        </sec>
        <sec id="cherubism.Penetrance">
          <title>Penetrance</title>
          <p>Penetrance is close to 100% in males and 50%-75% in females [<xref ref-type="bibr" rid="cherubism.REF.anderson.1962.5">Anderson &#x00026; McClendon 1962</xref>, <xref ref-type="bibr" rid="cherubism.REF.roginsky.2009.218">Roginsky et al 2009</xref>]. </p>
        </sec>
        <sec id="cherubism.Anticipation">
          <title>Anticipation</title>
          <p>Anticipation has not been described in cherubism.</p>
        </sec>
        <sec id="cherubism.Nomenclature">
          <title>Nomenclature</title>
          <p>Cherubism was first described as "familial multilocular cystic disease of the jaws" by <xref ref-type="bibr" rid="cherubism.REF.jones.1933.946">Jones [1933]</xref>; however, shortly thereafter he renamed the condition cherubism because of the resemblance of affected individuals to the cherubs in Renaissance art.</p>
        </sec>
        <sec id="cherubism.Prevalence">
          <title>Prevalence</title>
          <p>Prevalence is unknown. Variability of the cherubism phenotype may result in underdiagnosis of the condition.</p>
        </sec>
      </sec>
      <sec id="cherubism.Genetically_Related_Allelic_Di">
        <title>Genetically Related (Allelic) Disorders</title>
        <p>No other phenotypes are known to be associated with mutations in <italic toggle="yes">SH3BP2</italic>.</p>
      </sec>
      <sec id="cherubism.Differential_Diagnosis">
        <title>Differential Diagnosis</title>
        <p><bold>Noonan-like/multiple giant-cell lesion syndrome</bold> is a rare condition, with phenotypic overlap with <related-object link-type="booklink" source-id="gene" document-id="noonan" document-type="chapter">Noonan syndrome</related-object> and cherubism [<xref ref-type="bibr" rid="cherubism.REF.lee.2005.e11">Lee et al 2005</xref>]. It is characterized by dysmorphic features, developmental delay, short stature, pulmonary stenosis, and giant-cell lesions of bones and soft tissues. The giant-cell lesions are frequently found in the jaws and therefore persons with mild Noonan-like/multiple giant-cell lesion syndrome can be misdiagnosed with cherubism [<xref ref-type="bibr" rid="cherubism.REF.jafarov.2005.190">Jafarov et al 2005</xref>]. Mutations in <italic toggle="yes">PTPN11</italic> and <italic toggle="yes">SOS1</italic> [<xref ref-type="bibr" rid="cherubism.REF.hanna.2009.568">Hanna et al 2009</xref>] have been described in both familial and simplex cases (i.e., a single occurrence in a family) of Noonan-like/multiple giant-cell lesion syndrome. </p>
        <p><bold>Central giant-cell granuloma</bold> is a rare benign lesion that usually occurs in the mandible and maxilla. The lesions can lead to facial deformity and displacement of the teeth. The condition occurs in children and young adults, with a higher frequency in females. Histologically, central giant-cell granuloma cannot be separated from cherubism. The two conditions can be distinguished by radiologic findings because the majority of lesions in cases of central giant-cell granuloma are unilocular, whereas in cherubism the lesions are usually multilocular [<xref ref-type="bibr" rid="cherubism.REF.de_lange.2005.464">De Lange &#x00026; Van den Akker 2005</xref>]. A somatic mutation in <italic toggle="yes">SH3BP2</italic> has been identified in one individual with central giant-cell granuloma [<xref ref-type="bibr" rid="cherubism.REF.carvalho.2009.106">Carvalho et al 2009</xref>]. In the majority of individuals, the etiology of central giant-cell granuloma is unknown, although in most instances in which molecular genetic testing of <italic toggle="yes">SH3BP2</italic> was performed, testing was limited to exon 9. </p>
        <p><bold>Fibrous dysplasia.</bold> Fibrous dysplasia of the jaw is characterized by benign giant-cell lesions localized asymmetrically in the maxilla rather than the mandible. The condition usually presents in childhood and is progressive until after adolescence [<xref ref-type="bibr" rid="cherubism.REF.zenn.2001.259">Zenn &#x00026; Zuniga 2001</xref>]. Cherubism can be distinguished from fibrous dysplasia on a clinical basis. See <related-object link-type="booklink" source-id="gene" document-id="mccune-albright" document-type="chapter">Fibrous Dysplasia/McCune-Albright Syndrome</related-object>.</p>
        <p><bold>Hyperparathyroidism.</bold> Brown tumors are rare benign giant-cell lesions that arise as a result of parathyroid hormone effects on bone tissue in persons with hyperparathyroidism. Brown tumors can occur in both the maxilla and mandible [<xref ref-type="bibr" rid="cherubism.REF.lessa.2005.432">Lessa et al 2005</xref>]. The age of onset is usually in adulthood. Hyperparathyroidism can be distinguished from cherubism with biochemical investigations, since serum concentrations of calcium, parathyroid hormone, and alkaline phosphatase are elevated in hyperparathyroidism [<xref ref-type="bibr" rid="cherubism.REF.silva.2002.45">Silva et al 2002</xref>]. </p>
        <p><bold>Other.</bold> Cherubism is also part of Ramon syndrome, which is characterized by short stature, intellectual disability, and gingival fibromatosis. </p>
        <p>Cherubism has also been reported in association with <related-object link-type="booklink" source-id="gene" document-id="nf1" document-type="chapter">neurofibromatosis 1</related-object> [<xref ref-type="bibr" rid="cherubism.REF.mart_neztello.2005.793">Mart&#x000ed;nez-Tello et al 2005</xref>, <xref ref-type="bibr" rid="cherubism.REF.van_capelle.2007.905">van Capelle et al 2007</xref>], <related-object link-type="booklink" source-id="gene" document-id="fragilex" document-type="chapter">fragile X syndrome</related-object>, and a single case of coronal and sagittal craniosynostosis, which is likely to be a coincidental association [<xref ref-type="bibr" rid="cherubism.REF.stiller.2000.325">Stiller et al 2000</xref>]. </p>
      </sec>
      <sec id="cherubism.Management">
        <title>Management</title>
        <sec id="cherubism.Evaluations_Following_Initial">
          <title>Evaluations Following Initial Diagnosis</title>
          <p>To establish the extent of disease in an individual diagnosed with cherubism, the following evaluations are recommended:</p>
          <list list-type="bullet">
            <list-item>
              <p>Radiologic assessment to determine facial bone involvement </p>
            </list-item>
            <list-item>
              <p>Orthodontic assessment </p>
            </list-item>
            <list-item>
              <p>Ophthalmologic examination </p>
            </list-item>
            <list-item>
              <p>Assessment of family history </p>
            </list-item>
          </list>
        </sec>
        <sec id="cherubism.Treatment_of_Manifestations">
          <title>Treatment of Manifestations</title>
          <p>Treatment protocols for cherubism are not well established since both ends of the spectrum (mild clinically unrecognized cases and severe cases with extensive bone loss) are seen. Given that cherubism is considered to be a self-limited condition that improves over time, treatment should be tailored to the individual's needs. Depending on the severity, surgery may be needed for functional and esthetic concerns. </p>
          <list list-type="bullet">
            <list-item>
              <p><bold>Children with cherubism</bold> should be referred to a craniofacial clinic with pediatric experience for evaluation. A craniofacial clinic associated with a major pediatric medical center usually includes a surgical team, medical geneticist, dentist, orthodontic specialist, ophthalmologist, and social worker. </p>
            </list-item>
            <list-item>
              <p><bold>Surgical interventions</bold> include curettage with or without bone grafting [<xref ref-type="bibr" rid="cherubism.REF.kozakiewicz.2001.123">Kozakiewicz et al 2001</xref>, <xref ref-type="bibr" rid="cherubism.REF.roginsky.2009.218">Roginsky et al 2009</xref>]. Liposuction has also been used successfully to re-contour the jaws. Surgical interventions are likely to occur between ages five to 15 years in individuals with disfiguring enlargement of jaws or locally aggressive lesions associated with complications. </p>
            </list-item>
            <list-item>
              <p><bold>Orthodontic treatment</bold> is commonly required as the jaw distortion leads to permanent dental abnormalities including a malocclusive bite, premature loss of deciduous teeth, and widely spaced, misplaced, unerupted, or absent permanent teeth. </p>
            </list-item>
            <list-item>
              <p><bold>Ophthalmologic treatment</bold> is necessary in rare individuals in whom orbital manifestations such as lower lid retraction, proptosis, diplopia, globe displacement, and visual loss caused by optic atrophy are present. </p>
            </list-item>
          </list>
        </sec>
        <sec id="cherubism.Prevention_of_Secondary_Compli">
          <title>Prevention of Secondary Complications</title>
          <p>Early treatment (i.e., orthodontic and surgical reconstruction of the jaw) may reduce the risk for secondary complications such as upper airway obstruction, obstructive sleep apnea, and tooth displacement.</p>
        </sec>
        <sec id="cherubism.Surveillance">
          <title>Surveillance</title>
          <p>Generally, long-term follow up including clinical, radiographic, dental, orthodontic, and ophthalmologic evaluations is indicated [<xref ref-type="bibr" rid="cherubism.REF.silva.2007.567">Silva et al 2007</xref>]. </p>
        </sec>
        <sec id="cherubism.Evaluation_of_Relatives_at_Ris">
          <title>Evaluation of Relatives at Risk</title>
          <p>At-risk relatives could be offered clinical and radiographic evaluations given that manifestations may not be evident in all affected individuals. When the disease-causing mutation is known in the proband, molecular genetic testing can be used to evaluate relatives at risk for the disorder. This may allow mildly affected relatives to benefit from early surveillance and intervention. </p>
          <p>See <xref ref-type="sec" rid="cherubism.Related_Genetic_Counseling_Iss">Genetic Counseling</xref> for issues related to testing of at-risk relatives for genetic counseling purposes.</p>
        </sec>
        <sec id="cherubism.Therapies_Under_Investigation">
          <title>Therapies Under Investigation</title>
          <p>A mouse model for cherubism demonstrated that increased cytokine tumor necrosis factor &#x003b1; (TNF-&#x003b1;) production by myeloid cells is causative [<xref ref-type="bibr" rid="cherubism.REF.ueki.2007.71">Ueki et al 2007</xref>]. If TNF-&#x003b1; were found to be pathogenic in humans, anti-TNF therapies could provide new treatment options for cherubism. </p>
          <p>Search <ext-link xmlns:xlink="http://www.w3.org/1999/xlink" ext-link-type="uri" xlink:href="http://clinicaltrials.gov/">ClinicalTrials.gov</ext-link> for access to information on clinical studies for a wide range of diseases and conditions.</p>
        </sec>
        <sec id="cherubism.Other">
          <title>Other</title>
          <p>Results in the two reports to date on the use of calcitonin in the treatment of cherubism have not been promising [<xref ref-type="bibr" rid="cherubism.REF.hart.2000.34">Hart et al 2000</xref>, <xref ref-type="bibr" rid="cherubism.REF.lannon.2001.708">Lannon &#x00026; Earley 2001</xref>]. </p>
        </sec>
      </sec>
      <sec id="cherubism.Genetic_Counseling">
        <title>Genetic Counseling</title>
        <sec id="cherubism.Mode_of_Inheritance">
          <title>Mode of Inheritance</title>
          <p>Cherubism is inherited in an autosomal dominant manner. </p>
        </sec>
        <sec id="cherubism.Risk_to_Family_Members">
          <title>Risk to Family Members</title>
          <p><bold>Parents of a proband</bold>
</p>
          <list list-type="bullet">
            <list-item>
              <p>Some individuals diagnosed with cherubism have an affected parent. </p>
            </list-item>
            <list-item>
              <p>A proband with cherubism may have the disorder as the result of new gene mutation and no previous family history of cherubism will exist. The proportion of cases caused by <italic toggle="yes">de novo</italic> mutation is unknown since variable expressivity and reduced penetrance are observed in cherubism. </p>
            </list-item>
            <list-item>
              <p>If the pathogenic variant found in the proband cannot be detected in the DNA of either parent, two possible explanations are germline mosaicism in a parent or <italic toggle="yes">de novo</italic> mutation in the proband. Although no instances of germline mosaicism have been reported, it remains a possibility. </p>
            </list-item>
            <list-item>
              <p>Recommendations for the evaluation of parents of a proband with an apparent <italic toggle="yes">de novo</italic> mutation include physical examination and molecular genetic testing for the <italic toggle="yes">SH3BP2</italic> pathogenic variant identified in the proband. Evaluation of parents may determine that one is affected but has escaped previous diagnosis because of failure by health care professionals to recognize the syndrome and/or a milder phenotypic presentation. Therefore, an apparently negative family history cannot be confirmed until appropriate evaluations have been performed. </p>
            </list-item>
          </list>
          <p><bold>Sibs of a proband</bold>
</p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to the sibs of the proband depends on the genetic status of the proband's parents. </p>
            </list-item>
            <list-item>
              <p>If a parent of the proband is affected, the risk to the sibs is 50%. </p>
            </list-item>
            <list-item>
              <p>When the parents are clinically unaffected and/or the pathogenic variant found in the proband cannot be detected in the DNA of either parent, the risk to sibs is low, but greater than that of the general population because of the possibility of germline mosaicism. </p>
            </list-item>
          </list>
          <p><bold>Offspring of a proband.</bold> Each child of an individual with cherubism has a 50% chance of inheriting the pathogenic variant. </p>
          <p>
            <bold>Other family members of a proband</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The risk to other family members depends on the status of the proband's parents. </p>
            </list-item>
            <list-item>
              <p>If a parent is affected, his or her family members may be at risk. </p>
            </list-item>
          </list>
        </sec>
        <sec id="cherubism.Related_Genetic_Counseling_Iss">
          <title>Related Genetic Counseling Issues</title>
          <p>See Management, <xref ref-type="sec" rid="cherubism.Evaluation_of_Relatives_at_Ris">Evaluation of Relatives at Risk</xref> for information on testing at-risk relatives for the purpose of early diagnosis and treatment.</p>
          <p><bold>Considerations in families with apparent <italic toggle="yes">de novo</italic> mutation.</bold> When neither parent of a proband with an autosomal dominant condition has the pathogenic variant or clinical evidence of the disorder, it is likely that the proband has a <italic toggle="yes">de novo</italic> mutation. However, possible non-medical explanations including alternate paternity or maternity (e.g., with assisted reproduction) or undisclosed adoption could also be explored. </p>
          <p>
            <bold>Family planning</bold>
          </p>
          <list list-type="bullet">
            <list-item>
              <p>The optimal time for determination of genetic risk and discussion of the availability of prenatal testing is before pregnancy. </p>
            </list-item>
            <list-item>
              <p>It is appropriate to offer genetic counseling (including discussion of potential risks to offspring and reproductive options) to young adults who are affected or at risk.</p>
            </list-item>
          </list>
          <p><bold>DNA banking</bold> is the storage of DNA (typically extracted from white blood cells) for possible future use. Because it is likely that testing methodology and our understanding of genes, allelic variants, and diseases will improve in the future, consideration should be given to banking DNA of affected individuals. </p>
        </sec>
        <sec id="cherubism.Prenatal_Testing">
          <title>Prenatal Testing</title>
          <p>If the <italic toggle="yes">SH3BP2</italic> pathogenic variant has been identified in an affected family member, prenatal diagnosis for pregnancies at increased risk may be available from a clinical laboratory that offers either testing for this disease/gene or custom prenatal testing.</p>
          <p>Requests for prenatal testing for conditions which (like cherubism) do not affect intellect and have treatment available are not common. Differences in perspective may exist among medical professionals and within families regarding the use of prenatal testing, particularly if the testing is being considered for the purpose of pregnancy termination rather than early diagnosis. Although decisions about prenatal testing are the choice of the parents, discussion of these issues is appropriate.</p>
          <p><bold>Preimplantation genetic diagnosis (PGD)</bold> may be an option for some families in which the <italic toggle="yes">SH3BP2</italic> pathogenic variant has been identified. </p>
        </sec>
      </sec>
      <sec id="cherubism.Resources">
        <title>Resources</title>
      </sec>
      <sec id="cherubism.Molecular_Genetics">
        <title>Molecular Genetics</title>
        <p><bold>Gene structure.</bold> The <italic toggle="yes">SH3BP2</italic> transcript spans approximately 2.4 kb and comprises 13 exons. The gene was identified in a search for candidate tumor suppressor genes [<xref ref-type="bibr" rid="cherubism.REF.bell.1997.163">Bell et al 1997</xref>]. For a detailed summary of gene and protein information, see <related-object source-id="gene" document-id="cherubism" object-id="cherubism.molgen.TA">Table A</related-object>, <bold>Gene</bold>.</p>
        <p><bold>Pathogenic allelic variants.</bold>
<xref ref-type="bibr" rid="cherubism.REF.ueki.2001.125">Ueki et al [2001]</xref> first described missense mutations in <italic toggle="yes">SH3BP2</italic> in cherubism. Eleven missense mutations identified are located in exon 9 and affect four amino acids within a six-amino acid sequence [<xref ref-type="bibr" rid="cherubism.REF.ueki.2001.125">Ueki et al 2001</xref>, <xref ref-type="bibr" rid="cherubism.REF.lo.2003.37">Lo et al 2003</xref>, <xref ref-type="bibr" rid="cherubism.REF.lietman.2006.717">Lietman et al 2006</xref>]. A missense mutation in exon 4 in the pleckstrin homology domain has been described by <xref ref-type="bibr" rid="cherubism.REF.carvalho.2009.106">Carvalho et al [2009]</xref> in an individual with cherubism. </p>
        <p><bold>Normal gene product.</bold>
<italic toggle="yes">SH3BP2</italic> encodes the adaptor protein SH3-domain binding protein 2. It is required in several intracellular protein tyrosine kinase-dependent signaling pathways during hematopoietic cell differentiation and function [<xref ref-type="bibr" rid="cherubism.REF.foucault.2005.1106">Foucault et al 2005</xref>]. SH3BP2 positively regulates the activity of the transcription factor NFAT, which is involved in osteoclastogenesis [<xref ref-type="bibr" rid="cherubism.REF.lietman.2008.644">Lietman et al 2008</xref>]. </p>
        <p><bold>Abnormal gene product.</bold> Cherubism results from presumed gain-of-function mutations in <italic toggle="yes">SH3BP2</italic> [<xref ref-type="bibr" rid="cherubism.REF.lietman.2006.717">Lietman et al 2006</xref>]. A knock-in mouse model with the most common pathogenic variant in human <italic toggle="yes">SH3BP2</italic> (p.Pro416Arg) alters the bone quality and reduces osteoblast function [<xref ref-type="bibr" rid="cherubism.REF.wang.2010.1306">Wang et al 2010</xref>]. </p>
      </sec>
      <sec id="cherubism.References">
        <title>References</title>
        <sec id="cherubism.Literature_Cited">
          <title>Literature Cited</title>
          <ref-list id="cherubism.Literature_Cited.reflist0">
            <ref id="cherubism.REF.anderson.1962.5">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Anderson</surname>
                    <given-names>DE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>McClendon</surname>
                    <given-names>JL</given-names>
                  </name>
                </person-group>
                <year>1962</year>
                <article-title>Cherubism-hereditary fibrous dysplasia of the jaws; I genetic considerations.</article-title>
                <source>Oral Surg Oral Med Oral Pathol</source>
                <volume>15</volume>
                <supplement>Suppl 2</supplement>
                <fpage>5</fpage>
                <lpage>16</lpage>
              </element-citation>
            </ref>
            <ref id="cherubism.REF.battaglia.2000.573">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Battaglia</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Merati</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Magit</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Cherubism and upper airway obstruction.</article-title>
                <source>Otolaryngol Head Neck Surg</source>
                <volume>122</volume>
                <fpage>573</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">10740181</pub-id>
              </element-citation>
            </ref>
            <ref id="cherubism.REF.bell.1997.163">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Bell</surname>
                    <given-names>SM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Shaw</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Jou</surname>
                    <given-names>YS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Myers</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Knowles</surname>
                    <given-names>MA</given-names>
                  </name>
                </person-group>
                <year>1997</year>
                <article-title>Identification and characterization of the human homologue of SH3BP2, an SH3 binding domain protein within a common region of deletion at 4p16.3 involved in bladder cancer.</article-title>
                <source>Genomics</source>
                <volume>44</volume>
                <fpage>163</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">9299232</pub-id>
              </element-citation>
            </ref>
            <ref id="cherubism.REF.carroll.2001.38">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Carroll</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sullivan</surname>
                    <given-names>TJ</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Orbital involvement in cherubism.</article-title>
                <source>Clin Experiment Ophthalmol</source>
                <volume>29</volume>
                <fpage>38</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">11272784</pub-id>
              </element-citation>
            </ref>
            <ref id="cherubism.REF.carvalho.2009.106">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Carvalho</surname>
                    <given-names>VM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perdig&#x000e3;o</surname>
                    <given-names>PF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Amaral</surname>
                    <given-names>FR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Souza</surname>
                    <given-names>PEA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>De Marco</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gomez</surname>
                    <given-names>RS</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Novel mutations in the SH3BP2 gene associated with sporadic central giant lesions and cherubism.</article-title>
                <source>Oral Dis</source>
                <volume>15</volume>
                <fpage>106</fpage>
                <lpage>110</lpage>
                <pub-id pub-id-type="pmid">19017279</pub-id>
              </element-citation>
            </ref>
            <ref id="cherubism.REF.de_lange.2005.464">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>De Lange</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Van den Akker</surname>
                    <given-names>HP</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Clinical and radiological features of central giant-cell lesions of the jaw.</article-title>
                <source>Oral Surg Oral Med Oral Pathol Oral Radiol Endod</source>
                <volume>99</volume>
                <fpage>464</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">15772595</pub-id>
              </element-citation>
            </ref>
            <ref id="cherubism.REF.font.2003.1846">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Font</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Blanco</surname>
                    <given-names>G</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Soparkar</surname>
                    <given-names>CN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Patrinely</surname>
                    <given-names>JR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ostrowski</surname>
                    <given-names>ML</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Giant cell reparative granuloma of the orbit associated with cherubism.</article-title>
                <source>Ophthalmology</source>
                <volume>110</volume>
                <fpage>1846</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">13129888</pub-id>
              </element-citation>
            </ref>
            <ref id="cherubism.REF.foucault.2005.1106">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Foucault</surname>
                    <given-names>I</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Le Bras</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Charvet</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Moon</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Altman</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deckert</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>The adaptor protein 3BP2 associates with VAV guanine nucleotide exchange factors to regulate NFAT activation by the B-cell antigen receptor.</article-title>
                <source>Blood</source>
                <volume>105</volume>
                <fpage>1106</fpage>
                <lpage>13</lpage>
                <pub-id pub-id-type="pmid">15345594</pub-id>
              </element-citation>
            </ref>
            <ref id="cherubism.REF.gomes.2005.313">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Gomes</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Souza Setubal Destro</surname>
                    <given-names>MF</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Freitas Banzi</surname>
                    <given-names>EC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>dos Santos</surname>
                    <given-names>SH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Claro</surname>
                    <given-names>FA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Oliveira Nogueira</surname>
                    <given-names>T</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Aggressive behaviour of cherubism in a teenager: 4-years of clinical follow-up associated with radiographic and histological features.</article-title>
                <source>Dentomaxillofac Radiol</source>
                <volume>34</volume>
                <fpage>313</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">16120883</pub-id>
              </element-citation>
            </ref>
            <ref id="cherubism.REF.hanna.2009.568">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hanna</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Parfait</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Talaat</surname>
                    <given-names>IM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vidaud</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Elsedfy</surname>
                    <given-names>HH</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>SOS1 a new player in the Noonan-like/multiple giant cell lesion syndrome.</article-title>
                <source>Clin Genet.</source>
                <volume>75</volume>
                <fpage>568</fpage>
                <lpage>71</lpage>
                <pub-id pub-id-type="pmid">19438935</pub-id>
              </element-citation>
            </ref>
            <ref id="cherubism.REF.hart.2000.34">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Hart</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Schweitzer</surname>
                    <given-names>DH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Slootweg</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grootenhuis</surname>
                    <given-names>LS</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Man with cherubism.</article-title>
                <source>Ned Tijdschr Geneeskd.</source>
                <volume>144</volume>
                <fpage>34</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">10665301</pub-id>
              </element-citation>
            </ref>
            <ref id="cherubism.REF.jafarov.2005.190">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jafarov</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ferimazova</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reichenberger</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Noonan-like syndrome mutations in PTPN11 in patients diagnosed with cherubism.</article-title>
                <source>Clin Genet</source>
                <volume>68</volume>
                <fpage>190</fpage>
                <lpage>1</lpage>
                <pub-id pub-id-type="pmid">15996221</pub-id>
              </element-citation>
            </ref>
            <ref id="cherubism.REF.jones.1933.946">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Jones</surname>
                    <given-names>WA</given-names>
                  </name>
                </person-group>
                <year>1933</year>
                <article-title>Familial multilocular cystic disease of the jaws.</article-title>
                <source>Am J Cancer</source>
                <volume>17</volume>
                <fpage>946</fpage>
              </element-citation>
            </ref>
            <ref id="cherubism.REF.kozakiewicz.2001.123">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Kozakiewicz</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Perczynska-Partyka</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kobos</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Cherubism--clinical picture and treatment.</article-title>
                <source>Oral Dis</source>
                <volume>7</volume>
                <fpage>123</fpage>
                <lpage>30</lpage>
                <pub-id pub-id-type="pmid">11355438</pub-id>
              </element-citation>
            </ref>
            <ref id="cherubism.REF.ladhani.2003.552">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ladhani</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sundaram</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Joshi</surname>
                    <given-names>JM</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Sleep disordered breathing in an adult with cherubism.</article-title>
                <source>Thorax</source>
                <volume>58</volume>
                <fpage>552</fpage>
                <pub-id pub-id-type="pmid">12775879</pub-id>
              </element-citation>
            </ref>
            <ref id="cherubism.REF.lannon.2001.708">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lannon</surname>
                    <given-names>DA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Earley</surname>
                    <given-names>MJ</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Cherubism and its charlatans.</article-title>
                <source>Br J Plast Surg</source>
                <volume>54</volume>
                <fpage>708</fpage>
                <lpage>11</lpage>
                <pub-id pub-id-type="pmid">11728115</pub-id>
              </element-citation>
            </ref>
            <ref id="cherubism.REF.lee.2005.e11">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lee</surname>
                    <given-names>JS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tartaglia</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gelb</surname>
                    <given-names>BD</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fridrich</surname>
                    <given-names>K</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sachs</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Stratakis</surname>
                    <given-names>CA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Muenke</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Robey</surname>
                    <given-names>PG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Collins</surname>
                    <given-names>MT</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Slavotinek</surname>
                    <given-names>A</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Phenotypic and genotypic characterisation of Noonan-like/multiple giant cell lesion syndrome.</article-title>
                <source>J Med Genet.</source>
                <volume>42</volume>
                <fpage>e11</fpage>
                <pub-id pub-id-type="pmid">15689434</pub-id>
              </element-citation>
            </ref>
            <ref id="cherubism.REF.lessa.2005.432">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lessa</surname>
                    <given-names>MM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Sakae</surname>
                    <given-names>FA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsuji</surname>
                    <given-names>RK</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Filho</surname>
                    <given-names>BC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Voegels</surname>
                    <given-names>RL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Butugan</surname>
                    <given-names>O</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Brown tumor of the facial bones: case report and literature review.</article-title>
                <source>Ear Nose Throat J</source>
                <volume>84</volume>
                <fpage>432</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">16813033</pub-id>
              </element-citation>
            </ref>
            <ref id="cherubism.REF.lietman.2006.717">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lietman</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kalinchinko</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Deng</surname>
                    <given-names>X</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kohanski</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levine</surname>
                    <given-names>MA</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>Identification of a novel mutation of SH3BP2 in cherubism and demonstration that SH3BP2 mutations lead to increased NFAT activation.</article-title>
                <source>Hum Mutat</source>
                <volume>27</volume>
                <fpage>717</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">16786512</pub-id>
              </element-citation>
            </ref>
            <ref id="cherubism.REF.lietman.2008.644">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lietman</surname>
                    <given-names>SA</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Yin</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Levine</surname>
                    <given-names>MA</given-names>
                  </name>
                </person-group>
                <year>2008</year>
                <article-title>SH3BP2 is an activator of NFAT activity and osteoclastogenesis.</article-title>
                <source>Biochem Biophys Res Commun</source>
                <volume>371</volume>
                <fpage>644</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">18440306</pub-id>
              </element-citation>
            </ref>
            <ref id="cherubism.REF.lo.2003.37">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Lo</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Faiyaz-Ul-Haque</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kennedy</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aviv</surname>
                    <given-names>R</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tsui</surname>
                    <given-names>LC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Teebi</surname>
                    <given-names>AS</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Novel mutation in the gene encoding c-Abl-binding protein SH3BP2 causes cherubism.</article-title>
                <source>Am J Med Genet A.</source>
                <volume>121A</volume>
                <fpage>37</fpage>
                <lpage>40</lpage>
                <pub-id pub-id-type="pmid">12900899</pub-id>
              </element-citation>
            </ref>
            <ref id="cherubism.REF.mart_neztello.2005.793">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Mart&#x000ed;nez-Tello</surname>
                    <given-names>FJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Manj&#x000f3;n-Luengo</surname>
                    <given-names>P</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Martin-P&#x000e9;rez</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Montes-Moreno</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Cherubism associated with neurofibromatosis type 1, and multiple osteolytic lesions of both femurs: a previously undescribed association of findings.</article-title>
                <source>Skeletal Radiol</source>
                <volume>34</volume>
                <fpage>793</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">16096755</pub-id>
              </element-citation>
            </ref>
            <ref id="cherubism.REF.ozkan.2003.1005">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ozkan</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Varol</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Turker</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Aksakalli</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Basa</surname>
                    <given-names>S</given-names>
                  </name>
                </person-group>
                <year>2003</year>
                <article-title>Clinical and radiological evaluation of cherubism: a sporadic case report and review of the literature.</article-title>
                <source>Int J Pediatr Otorhinolaryngol</source>
                <volume>67</volume>
                <fpage>1005</fpage>
                <lpage>12</lpage>
                <pub-id pub-id-type="pmid">12907058</pub-id>
              </element-citation>
            </ref>
            <ref id="cherubism.REF.roginsky.2009.218">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Roginsky</surname>
                    <given-names>VV</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ivanov</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ovtchinnikov</surname>
                    <given-names>A</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khonari</surname>
                    <given-names>RH</given-names>
                  </name>
                </person-group>
                <year>2009</year>
                <article-title>Failial cherubism:the experience of the Moscow central institute for stomatology and maxillo-facial surgery.</article-title>
                <source>Int J Oral Maxillofac Surg</source>
                <volume>38</volume>
                <fpage>218</fpage>
                <lpage>23</lpage>
                <pub-id pub-id-type="pmid">19038533</pub-id>
              </element-citation>
            </ref>
            <ref id="cherubism.REF.silva.2002.45">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Silva</surname>
                    <given-names>EC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>de Souza</surname>
                    <given-names>PE</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Barreto</surname>
                    <given-names>DC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Dias</surname>
                    <given-names>RP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gomez</surname>
                    <given-names>RS</given-names>
                  </name>
                </person-group>
                <year>2002</year>
                <article-title>An extreme case of cherubism.</article-title>
                <source>Br J Oral Maxillofac Surg</source>
                <volume>40</volume>
                <fpage>45</fpage>
                <lpage>8</lpage>
                <pub-id pub-id-type="pmid">11883969</pub-id>
              </element-citation>
            </ref>
            <ref id="cherubism.REF.silva.2007.567">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Silva</surname>
                    <given-names>GC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Gomez</surname>
                    <given-names>RS</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Vieira</surname>
                    <given-names>TC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Silva</surname>
                    <given-names>EC</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Cherubism: long-term follow-up of 2 patients in whom it regressed without treatment.</article-title>
                <source>Br J Oral Maxillofac Surg.</source>
                <volume>45</volume>
                <fpage>567</fpage>
                <lpage>70</lpage>
                <pub-id pub-id-type="pmid">17030358</pub-id>
              </element-citation>
            </ref>
            <ref id="cherubism.REF.stiller.2000.325">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Stiller</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Urban</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Golder</surname>
                    <given-names>W</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tiziani</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reichenberger</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Frege</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Opitz</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peters</surname>
                    <given-names>H</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Craniosynostosis in cherubism.</article-title>
                <source>Am J Med Genet</source>
                <volume>95</volume>
                <fpage>325</fpage>
                <lpage>31</lpage>
                <pub-id pub-id-type="pmid">11186885</pub-id>
              </element-citation>
            </ref>
            <ref id="cherubism.REF.timo_ca.2000.336">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Timo&#x0015f;ca</surname>
                    <given-names>GC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>G&#x00103;le&#x0015f;anu</surname>
                    <given-names>RM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Cotu&#x00163;iu</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Grigora&#x0015f;</surname>
                    <given-names>M</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Aggressive form of cherubism: report of a case.</article-title>
                <source>J Oral Maxillofac Surg</source>
                <volume>58</volume>
                <fpage>336</fpage>
                <lpage>44</lpage>
                <pub-id pub-id-type="pmid">10716121</pub-id>
              </element-citation>
            </ref>
            <ref id="cherubism.REF.ueki.2007.71">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ueki</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lin</surname>
                    <given-names>CY</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Senoo</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ebihara</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Agata</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Onji</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Saheki</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kawai</surname>
                    <given-names>T</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Mukherjee</surname>
                    <given-names>PM</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reichenberger</surname>
                    <given-names>E</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olsen</surname>
                    <given-names>BR</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Increased myeloid cell responses to M-CSF and RANKL cause bone loss and inflammation in SH3BP2 "cherubism" mice.</article-title>
                <source>Cell</source>
                <volume>128</volume>
                <fpage>71</fpage>
                <lpage>83</lpage>
                <pub-id pub-id-type="pmid">17218256</pub-id>
              </element-citation>
            </ref>
            <ref id="cherubism.REF.ueki.2001.125">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Ueki</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Tiziani</surname>
                    <given-names>V</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Santanna</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fukai</surname>
                    <given-names>N</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Maulik</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Garfinkle</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ninomiya</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>doAmaral</surname>
                    <given-names>C</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peters</surname>
                    <given-names>H</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Habal</surname>
                    <given-names>M</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Rhee-Morris</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Doss</surname>
                    <given-names>JB</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Kreiborg</surname>
                    <given-names>S</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Olsen</surname>
                    <given-names>BR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reichenberger</surname>
                    <given-names>E</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Mutations in the gene encoding c-Abl-binding protein SH3BP2 cause cherubism.</article-title>
                <source>Nat Genet</source>
                <volume>28</volume>
                <fpage>125</fpage>
                <lpage>6</lpage>
                <pub-id pub-id-type="pmid">11381256</pub-id>
              </element-citation>
            </ref>
            <ref id="cherubism.REF.van_capelle.2007.905">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>van Capelle</surname>
                    <given-names>CI</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Hogeman</surname>
                    <given-names>PH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van der Sijs-Bos</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Heggelman</surname>
                    <given-names>BG</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Idowu</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Slootweg</surname>
                    <given-names>PJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Wittkampf</surname>
                    <given-names>AR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Flanagan</surname>
                    <given-names>AM</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>Neurofibromatosis presenting with a cherubism phenotype.</article-title>
                <source>Eur J Pediatr.</source>
                <volume>166</volume>
                <fpage>905</fpage>
                <lpage>9</lpage>
                <pub-id pub-id-type="pmid">17120035</pub-id>
              </element-citation>
            </ref>
            <ref id="cherubism.REF.von_wowern.2000.765">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Von Wowern</surname>
                    <given-names>N</given-names>
                  </name>
                </person-group>
                <year>2000</year>
                <article-title>Cherubism: a 36-year long-term follow-up of 2 generations in different families and review of the literature.</article-title>
                <source>Oral Surg Oral Med Oral Pathol Oral Radiol Endod</source>
                <volume>90</volume>
                <fpage>765</fpage>
                <lpage>72</lpage>
                <pub-id pub-id-type="pmid">11113824</pub-id>
              </element-citation>
            </ref>
            <ref id="cherubism.REF.wang.2010.1306">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>CJ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Chen</surname>
                    <given-names>IP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Koczon-Jaremko</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Boskey</surname>
                    <given-names>AL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ueki</surname>
                    <given-names>Y</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Khun</surname>
                    <given-names>L</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Reichenberger</surname>
                    <given-names>EJ</given-names>
                  </name>
                </person-group>
                <year>2010</year>
                <article-title>Pro416Arg cherubism mutation in sh3bp2 knock-in mice affects osteoblasts and alters bone mineral and matrix properties.</article-title>
                <source>Bone</source>
                <volume>46</volume>
                <fpage>1306</fpage>
                <lpage>15</lpage>
                <pub-id pub-id-type="pmid">20117257</pub-id>
              </element-citation>
            </ref>
            <ref id="cherubism.REF.wang.2006.322">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Wang</surname>
                    <given-names>CN</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Song</surname>
                    <given-names>YL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Peng</surname>
                    <given-names>B</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Lu</surname>
                    <given-names>DH</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fan</surname>
                    <given-names>MW</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Li</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Ye</surname>
                    <given-names>XQ</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Fan</surname>
                    <given-names>HL</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Bian</surname>
                    <given-names>Z</given-names>
                  </name>
                </person-group>
                <year>2006</year>
                <article-title>The aggressive form of cherubism: report of two cases in unrelated families.</article-title>
                <source>Br J Oral Maxillofac Surg</source>
                <volume>44</volume>
                <fpage>322</fpage>
                <lpage>4</lpage>
                <pub-id pub-id-type="pmid">16310907</pub-id>
              </element-citation>
            </ref>
            <ref id="cherubism.REF.zenn.2001.259">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Zenn</surname>
                    <given-names>MR</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Zuniga</surname>
                    <given-names>J</given-names>
                  </name>
                </person-group>
                <year>2001</year>
                <article-title>Treatment of fibrous dysplasia of the mandible with radical excision and immediate reconstruction: case report.</article-title>
                <source>J Craniofac Surg.</source>
                <volume>12</volume>
                <fpage>259</fpage>
                <lpage>63</lpage>
                <pub-id pub-id-type="pmid">11358100</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
        <sec id="cherubism.Suggested_Reading">
          <title>Suggested Reading</title>
          <ref-list id="cherubism.Suggested_Reading.reflist0">
            <ref id="cherubism.REF.de_lange.2007.499">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>de Lange</surname>
                    <given-names>J</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van Maarle</surname>
                    <given-names>MC</given-names>
                  </name>
                  <name name-style="western">
                    <surname>van den Akker</surname>
                    <given-names>HP</given-names>
                  </name>
                  <name name-style="western">
                    <surname>Redeker</surname>
                    <given-names>EJ</given-names>
                  </name>
                </person-group>
                <year>2007</year>
                <article-title>DNA analysis of the SH3BP2 gene in patients with aggressive central giant cell granuloma.</article-title>
                <source>Br J Oral Maxillofac Surg.</source>
                <volume>45</volume>
                <fpage>499</fpage>
                <lpage>500</lpage>
                <pub-id pub-id-type="pmid">16713042</pub-id>
              </element-citation>
            </ref>
            <ref id="cherubism.REF.peters.1979.307">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Peters</surname>
                    <given-names>WJ</given-names>
                  </name>
                </person-group>
                <year>1979</year>
                <article-title>Cherubism: a study of twenty cases from one family.</article-title>
                <source>Oral Surg Oral Med Oral Pathol</source>
                <volume>47</volume>
                <fpage>307</fpage>
                <lpage>11</lpage>
                <pub-id pub-id-type="pmid">285398</pub-id>
              </element-citation>
            </ref>
            <ref id="cherubism.REF.rice.2005.699">
              <element-citation publication-type="journal">
                <person-group>
                  <name name-style="western">
                    <surname>Rice</surname>
                    <given-names>DP</given-names>
                  </name>
                </person-group>
                <year>2005</year>
                <article-title>Craniofacial anomalies: from development to molecular pathogenesis.</article-title>
                <source>Curr Mol Med</source>
                <volume>5</volume>
                <fpage>699</fpage>
                <lpage>722</lpage>
                <pub-id pub-id-type="pmid">16305494</pub-id>
              </element-citation>
            </ref>
          </ref-list>
        </sec>
      </sec>
      <sec id="cherubism.Chapter_Notes">
        <title>Chapter Notes</title>
        <sec id="cherubism.Author_History">
          <title>Author History </title>
          <p>Berivan Baskin, PhD, FCCMG, FACMG (2007-present)Sarah Bowdin, BM, MSc, MRCPCH (UK) (2011-present)Peter N Ray, PhD, FCCMG, FACMG (2007-present)Ahmad Teebi, MD, FRCPC, FACMG; Weill Cornell Medical College - Qatar (2007-2011)</p>
        </sec>
        <sec id="cherubism.Revision_History">
          <title>Revision History</title>
          <list list-type="bullet">
            <list-item>
              <p>1 September 2011 (me) Comprehensive update posted live</p>
            </list-item>
            <list-item>
              <p>26 February 2007 (me) Review posted to live Web site </p>
            </list-item>
            <list-item>
              <p>8 December 2006 (pr) Original submission </p>
            </list-item>
          </list>
        </sec>
      </sec>
    </body>
  </book-part>
</book-part-wrapper>
